ANG Lifesciences India Limited Share Price

ANG Lifesciences India Limited Share Price

BSE: 540694
|
Pharmaceuticals
|
S Cap
₹ 37.97
+0.00 (0.00%)
1D
Last updated 23 Sep, 2026, 10:15 IST

ANG Lifesciences India Limited Share Price Today

As of 23 Sep 2026, ANG Lifesciences India Limited share price is ₹37.97. The stock opened at ₹37.97, compared to its previous close of ₹37.97. During today's trading session, ANG Lifesciences India Limited share price moved in the range of ₹37.97 to ₹37.97, with an average price of ₹37.97 for the day. Looking at its last 52-week, the stock has touched a low of ₹17.63 and a high of ₹49.69.

₹37.97
0.00% up today
₹37.97
1D LOW
1D HIGH

ANG Lifesciences India Limited Returns Calculator

Circuit
L
H
₹37.22
₹38.72
52-week
L
H
₹17.63
₹49.69

About ANG Lifesciences India Limited

ANG Lifesciences India Limited Share Price
ISIN
INE236W01016
Sector Market Cap
₹ 49.58 Cr

ANG Lifesciences India Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing and marketing of finished pharmaceutical formulations in a dosage form of sterile dry powder injection vials. It operates in two segments, namely pharmaceuticals and printing and packaging. The Company's product portfolio includes various products comprising therapeutic categories, such as Antibiotics, Antiviral, Antimalarial, Antiulcer, Carbapenem, Corticosteroid, Penicillin and Beta Lactamase Inhibitor. The Company’s product category includes Dry Powder Injection, Liquid Injections, Hard Gelatin Capsule, Tablet Beta Lactum, Tablets, Liquid Suspension /Syrup, Ointment/Creams, and Soft Gelatin Capsule. Its Dry Powder Injection products include Ampicillin & Cloxacillin for injection 500mg, Azetronam for Injection USP 500mg, Ampicillin Injection 1.0gm, Ceftriaxone Injection 250mg, Amoxycillin & Potassium Clavulanate for injection 1.2gm, and others.

ANG Lifesciences India Limited Financial Highlights

  • Revenue: ANG Lifesciences India Limited reported revenue of ₹93.43 crore in FY26 vs ₹94.86 crore in FY25. It showed a decrease of 1.51% on a yearly basis.
  • Operating Profit: ANG Lifesciences India Limited reported an operating loss of ₹13.01 crore in FY26 vs ₹15.70 crore in FY25. It showed an increase of 17.13% on a year-on-year basis.
  • Net Profit: ANG Lifesciences India Limited reported a net loss of ₹11.08 crore in FY26 vs ₹12.41 crore in FY25. It showed an increase of 10.72% on a yearly basis.

ANG Lifesciences India Limited Quarterly Result Highlights

  • ANG Lifesciences India Limited reported revenue of ₹15.41 crore in Jun 2026, compared with ₹23.67 crore in Mar 2026, representing a decrease of 34.90% on a quarter-on-quarter (QoQ) basis.
  • ANG Lifesciences India Limited reported an operating loss of ₹5.58 crore in Jun 2026, compared with ₹1.10 crore in Mar 2026, representing a decrease of 407.27% on a quarter-on-quarter (QoQ) basis.
  • ANG Lifesciences India Limited reported a loss of ₹4.24 crore in Jun 2026, compared with ₹1.38 crore in Mar 2026, reflecting a decrease of 207.25% on a QoQ basis.
  • The earnings per share (EPS) of ANG Lifesciences India Limited stood at ₹9.42 during Jun 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
70.60%
FII
0.00%
Other DII
0.00%
Retail and other
29.40%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
49.58
P/E
-3.72
P/B
0.94
ROE
-20.96%
D/E
1.07
ROCE
-3.83%
Div. Yield
0.00%
EPS(TTM)
-3.52
Turnover
0.43
EV/EBITDA
-93.43
Net Margin
0.00%
Op. Margin
0.00%
ROA
-6.37%
Quick Ratio
0.00
Curr. Ratio
2.23
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
ANG Lifesciences outperforming all market indices
Step 1 of 5
Valuation
Overvalued
ANG Lifesciences appears overvalued compared to its peers
Step 3 of 5
Earnings
Neutral
ANG Lifesciences earnings growth is positive
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,48,196.0036.515.2913.74%0.6117.33%93.240.86%0.4810.90
Divis Laboratories2,50,390.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,88,967.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,888.0033.253.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,00,364.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,00,329.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma98,803.9026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

ANG Lifesciences India Limited Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹92.85₹146.11₹219.89₹354.30
Other Income₹2.02₹0.70₹9.72₹0.90
Total Revenue₹94.87₹146.81₹229.61₹355.20
Total Expenses₹110.57₹155.79₹226.99₹301.70
Profit Before Tax-₹15.70-₹10.71₹2.63₹53.50
Tax-₹3.29-₹0.57₹2.89₹13.18
Profit After Tax-₹12.41-₹10.14-₹0.26₹40.32
EPS - Basic-₹9.42-₹7.61₹0.36₹39.09
EPS - Diluted-₹9.42-₹7.61₹0.36₹39.09

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹15.70-₹10.71₹2.63₹53.50
Income before WC changes-₹2.25₹9.18₹23.32₹70.30
Change in Assets₹9.72₹10.86₹7.05-₹75.62
Change in Liabilities-₹3.50-₹16.12-₹0.53₹30.57
Change in WC₹6.22-₹5.27₹6.51-₹45.05
Cash flow from Operations-₹0.26-₹9.49₹26.38₹24.72
Cash flow from Investing-₹1.59₹19.89-₹9.33-₹44.41
Cash flow from Financing₹1.68-₹10.40-₹17.07₹19.93
Total Cash Flow-₹0.16-₹0.01-₹0.02₹0.23
Cash (Start of the year)₹0.32₹0.32₹0.35₹0.11
Cash (End of the year)₹0.16₹0.32₹0.32₹0.35

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹68.56₹69.13₹94.51₹98.22
Current Assets₹161.03₹173.31₹183.15₹192.81
Total Assets₹229.59₹242.44₹277.66₹291.03
Current Liabilities₹143.44₹144.57₹162.28₹166.29
Net Current Asset₹17.59₹28.75₹20.87₹26.52
Non-Current Liabilities₹22.18₹21.59₹29.16₹40.97
Equity Capital₹63.98₹76.28₹86.22₹83.77
Total Equity & Liabilities₹229.59₹242.44₹277.66₹291.03

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Revenue₹89.91₹131.37₹207.01₹348.67
Other Income₹2.44₹0.84₹9.84₹0.95
Total Revenue₹92.35₹132.20₹216.85₹349.62
Total Expenses₹105.29₹139.34₹214.78₹296.56
Profit Before Tax-₹12.94-₹8.87₹2.07₹53.06
Tax-₹2.59-₹0.22₹2.73₹13.35
Profit After Tax-₹10.34-₹8.65-₹0.66₹39.71
EPS - Basic-₹7.86-₹6.48₹0.04₹38.51
EPS - Diluted-₹7.86-₹6.48₹0.04₹38.51

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Profit before tax-₹12.94-₹8.87₹2.07₹53.06
Income before WC changes-₹1.19₹8.59₹20.40₹67.89
Change in Assets₹9.41₹8.29₹12.72-₹65.35
Change in Liabilities-₹6.33-₹16.61-₹3.76₹25.43
Change in WC₹3.09-₹8.32₹8.96-₹39.92
Cash flow from Operations-₹2.29-₹13.13₹26.01₹27.39
Cash flow from Investing-₹1.63₹20.02-₹9.35-₹42.50
Cash flow from Financing₹3.92-₹7.00-₹16.75₹15.29
Total Cash Flow-₹0.01-₹0.12-₹0.08₹0.17
Cash (Start of the year)₹0.09₹0.20₹0.29₹0.11
Cash (End of the year)₹0.08₹0.09₹0.20₹0.29

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2025Mar 2024Mar 2023Mar 2022
Non-Current Assets₹62.10₹59.05₹84.30₹87.12
Current Assets₹146.57₹158.37₹168.21₹181.57
Total Assets₹208.67₹217.43₹252.51₹268.68
Current Liabilities₹125.37₹125.90₹146.36₹153.92
Net Current Asset₹21.19₹32.48₹21.85₹27.65
Non-Current Liabilities₹16.49₹14.46₹20.62₹31.28
Equity Capital₹66.81₹77.07₹85.54₹83.48
Total Equity & Liabilities₹208.67₹217.43₹252.51₹268.68
* All values are in INR Crore
Qty
Bid
150
38.7
0
0
0
0
0
0
0
0
Ask
Qty
37.97
13
38.7
100
0
0
0
0
0
0
Bid Total: 150
Ask Total: 113
Buy orders: 57%
Sell orders: 43%
Bearish
5
Neutral
1
Bullish
2
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
73.03
Bullish
ATR (14)
0.57
Neutral
STOCH(9,6)
100
Bearish
STOCH RSI (14)
100
Bearish
ADX(9)
48.79
Bearish
UO(9)
83.46
Bearish
ROC(12)
13.58
Bullish
WillR(14)
0
Bearish
Period
Simple value
Exponential vaue
5D
37.53
37.5
10D
36.68
36.51
20D
34.06
34.91
50D
33.06
33.27
100D
31.9
31.75
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
16 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
ANG Lifesciences India Limited Share Price
ANG Lifesciences India Limited
Pharmaceuticals
Add Stock
Add Another

ANG Lifesciences India Limited Share Price FAQs

ANG Lifesciences India Limited share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837